UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in LNSR — LENSAR, Inc.
CIK 861177
NEW YORK, NY
Position in LNSR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,951
New position
Shares Held
1,502
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 57%
Shared 0%
None 43%
Position in Medical Devices
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $6,140,526,672 across 63 Medical Devices names. LNSR ranks #52 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
13,198,740 | $1,355,114,632 | |
| 2 | BSX |
Boston Scientific Corp
|
13,513,771 | $847,989,125 | |
| 3 | MDT |
Medtronic plc
|
9,733,748 | $843,429,259 | |
| 4 | SYK |
Stryker Corp
|
2,208,201 | $725,592,760 | |
| 5 | DXCM |
Dexcom Inc
|
9,746,174 | $612,059,721 | |
| 6 | EW |
Edwards Lifesciences Corp
|
5,458,148 | $437,088,487 | |
| 7 | STE |
STERIS plc
|
1,253,502 | $277,186,892 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
2,521,213 | $179,459,935 |
All Filings in LNSR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,951 | 1,502 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||